In Silico World final meeting: resources for In Silico Trials

Tuesday, Sept. 3rd, afternoon

In Silico World is a four-year collaborative project funded by the European Commission to lower the barriers that slow down the adoption of In Silico Trials, the use of computer modelling and simulation in derisking new medical products. As the project moves to its conclusion in December 2024, the project’s final meeting will be a public event where the consortium will present to the community all the resources (many available in open-access) that we developed to facilitate In Silico Trials. These include validation data collections, resources to assist with regulatory qualification, resources to simplify communication with specific stakeholders, educational resources, resources for scalability and computational efficiency, and resources to find the appropriate business models and understand the ethical and legal aspects. The event will conclude with refreshments served within a showcase where the 11 solutions for In Silico Trials developed in the project will be demoed.

Agenda

13:00 – 13:20 In Silico Trials: a SWOT analysis, Marco Viceconti, Alma Mater Studiorum – University of Bologna

13:20 – 13:40 Validation collections, Frans Van der Vosse

13:40 – 14:00 Regulatory resources, Francesco Pappalardo

14:00 – 14:20 Engagement resources, Liesbet Geris

14:20 – 14:40 Computational resources, Maciej Malawski

14:40 – 15:00 Educational resources, Jos vander Sloten

15:00 – 15:20 Business models, Vicenzo Carbone

15:20 – 15:40 Legal resources, Elisabetta Biasin

15:40 – 16:00 Conclusions, Panel discussion with all speakers

16:00 – 18:00 Showcase of the ISW solutions (refreshments will be served), Target audience & learning objectives

The event interests all those with a professional or educational interest in In Silico Trials. This includes biomedical engineering and biomedicine students, PhD students in medical technologies, academic researchers, industry experts working in the development and derisking of medical products, medical industry management, specialists in companies developing tools for In Silico Trials, experts in regulatory agencies and notified bodies, experts in legal and ethical issues in computational medicine, and healthcare managers and policymakers.